DRUG R&D to Revenue
0.00%Fiscal year
Period ending:
DRUG FY R&D/Revenue%
1.00%-1.00%
2019-09-302025-09-30
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
DRUG r&d to revenue history
R&D spending as percentage of revenue. The available annual fiscal periods series contains 7 observations from Sep 30, 2019 to Sep 30, 2025.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |
Compare r&d to revenue
All DRUG financial metrics · DRUG stock overview · How to interpret financial metrics
